Zhongjing Technology: Changzhou Jinhong, a shareholder, intends to reduce its shareholding by no more than 3%. Zhongjing Technology announced that Changzhou Jinhong Enterprise Management Partnership (Limited Partnership), a shareholder holding more than 5%, intends to reduce its shareholding in the company by means of centralized bidding and block trading, with the reduction amount not exceeding 18,886,100 shares, that is, not exceeding 3% of the company's total share capital. The reduction price will be determined according to the market price when the reduction is implemented. This reduction will be carried out within three months after 15 trading days from the date of disclosure of this announcement.ECB: There is no pre-commitment to a specific interest rate path. The investment portfolio of the asset purchase plan declines at a controllable and predictable rate.Huadong Pharmaceutical has established a new company in Jiaxing with a registered capital of 60 million yuan. According to Tianyancha App, Huadong Pharmaceutical (Jiaxing) Co., Ltd. was recently established with Zhu Li as its legal representative and a registered capital of 60 million yuan. Its business scope includes drug wholesale, drug retail, decoction service for Chinese herbal pieces, third-class medical device operation, drug Internet information service, drug import and export, third-class medical device rental and medical device Internet information service. According to shareholder information, the company is wholly owned by Huadong Pharmaceutical (000963).
Weilai Li Bin: Fang Hongbo, chairman of Midea, became the chief experience officer of Weilai ET9, and will test drive together. Li Bin, founder, chairman and CEO of Weilai, released Weibo on December 12th, saying that Fang Hongbo, chairman of Midea, became the chief experience officer of Weilai ET9, and will test drive this upcoming administrative flagship together. Li Bin said that he asked Fang Hongbo three questions, and Fang Hongbo's answer about market competition was very good: "Actively participate in involution, compare cost and efficiency, and at the same time bravely jump out of involution, don't roll on the floor, and pierce the ceiling."It is reported that the price of iPhone 18 Pro's further use of TSMC's 2nm chip will increase by 70%. It is reported that in 2026, the A20 Pro processor of iPhone 18 Pro will be produced by TSMC's 2 nm process for the first time, and the chip price will rise from the current 50 US dollars to 85 US dollars, with an increase of 70%. With the high cost, the price of iPhone 18 Pro may increase. (Taiwan Province Business Times)Indian Minister of Steel: Considering the growth of domestic consumption, there is no possibility of assets stranded in the future.
China Chengtong and China Yizhong set up an enterprise management center with a capital contribution of 6.25 billion yuan. According to Tianyancha App, Zhongcheng (Beijing) Enterprise Management Center (Limited Partnership) was recently established. The executive partner is Yizhong Group Sunac Technology Development Co., Ltd., with a capital contribution of 6.25 billion yuan. The business scope is enterprise management and enterprise management consulting. It is owned by China Chengtong's Beijing Chengtong Capital Investment Co., Ltd., China Yizhong Group Co., Ltd. and its subsidiary Sunac Technology Development Co., Ltd.The latest collection price of the heavy anticancer star drug Regofibril has dropped to a minimum of more than 4 yuan per tablet. The reporter learned at the scene of the tenth batch of drug collection that the anti-tumor drug Regofibril tablets with annual sales of more than 1 billion yuan have been auctioned by this collection, and the price has almost dropped to between 4 yuan and 6 yuan, which is 90% lower than the price limit. Nanjing Zhengda Tianqing is expected to win the bid in the first round of quotation. Regofibril can treat colorectal cancer, liver cancer and other cancers. Its original research manufacturer is Bayer, which occupies almost all the market share in China. The price of this collection is about 172 yuan per tablet. (science and technology innovation board Daily)The European Central Bank cut interest rates by 25 basis points, warning that economic growth will slow down. The European Central Bank cut interest rates by 25 basis points to 3%, and warned that economic growth will be weaker than its previous forecast. This is the fourth time that the European Central Bank has cut interest rates since June, bringing the benchmark interest rate to its lowest level since March 2023. At the same time, the European Central Bank warned that the euro zone economy will only grow by 1.1% in 2025, lower than its forecast of 1.3% in September. It was widely expected that the European Central Bank would cut interest rates. Investors expect that the European Central Bank will cut interest rates more than the Federal Reserve next year, because it is widely expected that the economic growth of the euro zone will lag behind that of the United States. The euro zone's export-dependent economy is also vulnerable to Trump's threat to impose tariffs of up to 20% on all American imports.